Shucai T. Zhang
9 Beiguan Avenue
Tongzhou, 101149, China
Tongzhou, 101149, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
The effectiveness and safety of duodenoscopy in the treatment of active bleeding in duodenal diverticula: a retrospective study
Journal: Zhonghua nei ke za zhi
Published: March 16, 2026
Analysis of the efficacy and safety of magaldrate granules quadruple therapy in the treatment of Helicobacter pylori infection
Journal: Zhonghua yi xue za zhi
Published: January 29, 2026
Application research of endoscopic-laparoscopic regional gastric resection combined with sentinel lymph node basin dissection in patients with early gastric cancer
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: May 30, 2025
Pulse splitter using a moving space-time electron plasma grating.
Journal: Physical review. E
Published: January 06, 2025
Effectiveness of endoscopic ultrasound-guided biliary drainage in patients experiencing obstructive jaundice due to unsuccessful endoscopic retrograde cholangiopancreatography
Journal: Zhonghua nei ke za zhi
Published: October 07, 2024
Research Progresses on the Effects of CCL4 on Immune Escape in Tumor Microenvironment
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: September 25, 2024
Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer.
Journal: The Lancet regional health. Western Pacific
Published: April 16, 2024
Nonlinear saturation of the two-plasmon decay instability in magnetized plasmas.
Journal: Physical review. E
Published: April 01, 2024
Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC: Final overall survival results from a phase 2 trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 22, 2024
Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 14, 2023
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study.
Journal: Translational lung cancer research
Published: September 06, 2023
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study.
Journal: Cancer communications (London, England)
Published: July 20, 2023
Last Updated: 09/26/2026